Improving clinical trial recruitment has long been a priority for pharma, but despite having a plethora of new innovations at their disposal, along with a sincere commitment to patient cent
Patient engagement is one of the most important drivers for improving healthcare delivery but, as Krystallia Pantiri explains, approaches by European health technology assessment (HTA) bodi
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
